• 1
    Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445450.
  • 2
    Merli M, Riggio O, Dally L, and the Policentrica Italiana Nutrizione Cirrosi. Does malnutrition affect survival in cirrhosis? HEPATOLOGY 1996; 23: 10411046.
  • 3
    Owen OE, Trapp VE, Reichard GA, Mozzoli MA, Moctezuma J, Paul P, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72: 18211832.
  • 4
    Swart GR, Zillikens MC, van Vuure JK, van den Berg JWO. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989; 299: 12021203.
  • 5
    Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113120.
  • 6
    Verboeket-van de Venne WPHG, Westerterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut 1995; 36: 110116.
  • 7
    Zillikens MC, van den Berg JWO, Wattimena JLD, Rietveld T, Swart GR. Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. J Hepatol 1993; 17: 377383.
  • 8
    Fukushima H, Miwa Y, Ida E, Kuriyama S, Toda K, Shimomura Y, et al. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration. J Parenter Enter Nutr 2003; 27: 315322.
  • 9
    Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enter Nutr 1997; 21: 9699.
  • 10
    Miwa Y, Shiraki M, Kato M, Tajika M, Mohri H, Murakami N, et al. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatol Res 2000; 18: 184189.
  • 11
    Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol Res 2001; 21: 199204.
  • 12
    Okamoto M, Sakaida I, Tsuchiya M, Suzuki C, Okita K. Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res 2003; 27: 4550.
  • 13
    Sakaida I, Tsuchiya M, Okamoto M, Okita K. Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol Res 2004; 30S: S67S72.
  • 14
    Aoyama K, Tsuchiya M, Mori K, Kubo Y, Shiraishi K, Sakaquchi E, et al. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res 2007; 37: 608614.
  • 15
    Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2003; 25: 285294.
  • 16
    Beddoe AH, Streat SJ, Hill GL. Evaluation of an in vivo prompt gamma neutron activation facility for body composition studies in critically ill intensive care patients: results on 41 normals. Metabolism 1984; 33: 270280.
  • 17
    Sutcliffe JF, Mitra S, Hill GL. In vivo measurement of total body carbon using 238Pu/Be neutron sources. Phys Med Biol 1990; 35: 10891098.
  • 18
    Hill GL, Monk D, Plank LD. Measuring body composition in intensive care patients. In: WilmoreD, CarpentierY, eds. Metabolic Support of the Critically Ill Patient. Berlin, Germany: Springer-Verlag; 1993: 318.
  • 19
    Plank LD, Metzger DJ, McCall JL, Barclay KL, Gane EJ, Streat SJ, et al. Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery. Ann Surg 2001; 234: 245255.
  • 20
    Morgan DB, Hill GL, Burkinshaw L. The assessment of weight loss from a single measurement of body weight: the problems and limitations. Am J Clin Nutr 1980; 33: 21012105.
  • 21
    Kiebzak GM, Leamy LJ, Pierson LM, Nord RH, Zhang ZY. Measurement precision of body composition variables using the Lunar DPX-L densitometer. J Clin Densitom 2000; 3: 3541.
  • 22
    Plank LD, Monk DN, Gupta R, Franch-Arcas G, Pang J, Hill GL. Body composition studies in intensive care patients: comparison of methods of measuring total body water. Asia Pacific J Clin Nutr 1995; 4: 125129.
  • 23
    International Committee on Radiological Protection. Report of the Task Force on Reference Man. Oxford, UK: Pergamon Press; 1975:Report No. 23.
  • 24
    Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007; 85: 12571266.
  • 25
    Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473483.
  • 26
    Carithers RL, Sugano D, Bayliss M. Health assessment for chronic HCV infection. Dig Dis Sci 1996; 41(Suppl): 75S80S.
  • 27
    Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu M-A, Ware JE. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998; 7: 3955.
  • 28
    Tapsell LC, Brenninger V, Barnard J. Applying conversation analysis to foster accurate reporting in the diet history interview. J Am Diet Assoc 2000; 100: 818824.
  • 29
    Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. HEPATOLOGY 1995; 21: 680688.
  • 30
    Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995; 80: 11481157.
  • 31
    Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth-hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997; 27: 796802.
  • 32
    Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997; 13: 185190.
  • 33
    Scharf J-G, Schmitz F, Frystyk J, Skjaerbaek C, Moesus H, Blum WF, et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996; 25: 689699.
  • 34
    Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway RC, Beitins IZ, et al. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 12471250.
  • 35
    Clemmons DR, Underwood LE, Dickerson RN, Brown RO, Hak LJ, MacPhee RD, et al. Use of plasma somatomedin-C/insulin-like growth factor-I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985; 41: 191198.
  • 36
    Mendenhall CL, Chernausek SD, Ray MB, Gartside PS, Roselle GA, Grossman CJ, et al. The interactions of insulin-like growth factor I (IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease: V. A. Cooperative Study on alcoholic hepatitis VI. Alcohol Alcoholism 1989; 24: 319329.